Biosimilars have been around in the U.S. since Zarxio was approved by the FDA in 2015, and the vernacular can get confusing. Dr. Shannon Smallwood, Senior Pharmacy Executive and host Gretchen Brummel address the basics of biosimilars for the masses.

Guest speaker:

Shannon Smallwood, PharmD, BCPS

Senior Pharmacy Executive

Vizient

Moderator:

Gretchen Brummel, PharmD, BCPS

Pharmacy Executive Director

Vizient Center for Pharmacy Practice Excellence

Show Notes:

[00:40-01:25] Biosimilar definition

[01:26-01:52] Comparisons to generic medications

[01:53-02:42] Difference in biobetters and biologics

[02:43-05:18] History of biosimilars

[05:19 -07:05] Payer responsive model

[07:06-08:16] What frontline staff should know about biosimilars

[08:17-09:18] What Shannon is watching for next year

Links | Resources:

NCCN Pharmacy Directors Forum Click here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed